RT@sciencemagazine CD40 immunotherapy shows efficacy in treating pancreatic cancer in mice, humans Abstract: Immunosuppressive tumor microenvironments can restrain antitumor immunity, particularly in pancreatic ductal adenocarcinoma (PDA). Because CD40 activation can reverse immune suppression and drive antitumor T cell responses, we … Read More